Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Marijuana Abuse 2Recurrence 1Parasomnias 1Neoplasms 1Nausea 1Marijuana Use 1Glioblastoma 1Brain Neoplasms 1Anxiety Disorders 1Advanced Malignant Solid Tumor 1

Interventions

Acetaminophen 4Surveys and Questionnaires 3Saline Solution 3nabiximols 2Standard of Care 2Radiofrequency Ablation 2Oxycodone 2Music Therapy 2Morphine 2Methods 2Electroacupuncture 2Dronabinol 2siltuximab 1pegfilgrastim 1oxycodone-acetaminophen 1erenumab 1Yoga 1Xylitol 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Telemedicine 1STAMP-I protocol 1Remifentanil 1Range of Motion, Articular 1Psychiatric Rehabilitation 1Preoperative Exercise 1Physical Therapy Modalities 1Pentoxifylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain × nabiximols × 1 year × Clear all
NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡